Abstract
Pancreatic neuroendocrine neoplasms (PanNENs) are tumors with neuroendocrine differentiation and are divided into functioning (syndromic) or non-functioning based on the clinical syndromes. Insulinomas are the most common functioning NETs. Non-functioning neuroendocrine tumors (NFNETs) account for up to 70–80% of all pancreatic NTEs. Pancreatic NFNETs are discovered incidentally or become clinically noticeable because of their large size.
The diagnosis of pancreatic NENs is usually based on clinical and biochemical workup. Imaging is needed to localize the functioning tumor and characterize the non-functioning tumor providing local and distant staging.
The current chapter is based on the original chapter written by Paola Capelli, Mirko D’Onofrio, Stefano Crosara, Paolo Tinazzi Martini, Riccardo De Robertis, Matteo Fassan, Stefano Gobbo, Aldo Scarpa, and Roberto Pozzi Mucelli in the previous edition of the book.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Procacci C, Biasiutti C, Carbognin G, et al. Pancreatic neoplasms and tumor-like conditions. Eur Radiol. 2001;11(Suppl 2):S167–92.
Dixon E, Pasieka JL. Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol. 2007;19:30–5.
Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumors of the pancreas. Br J Surg. 2008;95:627–35.
Guilmette JM, Nosé V. Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances. Adv Anat Pathol. 2019;26(1):13–30.
Crona J, Skogseid B. Genetics of neuroendocrine tumors. Eur J Endocrinol. 2016;174(6):R275–90.
Iacovazzo D, Flanagan SE, Walker E, et al. MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci U S A. 2018;115(5):1027–32.
Tortora G, Amato E, Pederzoli P, Scarpa A, Chang DK, Nones K, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65–7.
Hruban RH, Pitman MB, Klimstra DS, American Registry of Pathology, Armed Forces Institute of Pathology (US). Tumors of the pancreas. Washington, DC: Armed Forces Institute of Pathology; 2007.
D’Onofrio M, Gallotti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev Med Dev. 2010;7:257–73.
O’Grady HL, Conlon KC. Pancreatic neuroendocrine tumors. Eur J Surg Oncol. 2008;34:324–32.
Tamm EP, Kim EE, Chaan S. Imaging of neuroendocrine tumors. Hematol Oncol Clin N Am. 2007;21:409–32.
Lee LS. Diagnosis of pancreatic neuroendocrine tumors and the role of endoscopic ultrasound. Gastroenterol Hepatol. 2010;6:520–2.
Ros PR, Mortele KJ. Imaging features of pancreatic neoplasms. JBR-BTR. 2001;84:239–49.
Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.
Yachida S, Vakiani E, White CM, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36(2):173–84.
Bosman FT, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2010.
Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 5th ed. Lyon; 2019. ISBN 978-92-832-4499-8.
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. IARC press; 2016. ISBN: 978-1-119-26357-9.
Inzani F, Petrone G, Rindi G. The New World health organization classification for pancreatic neuroendocrine neoplasia. Endocrinol Metab Clin N Am. John Wiley & Sons, Ltd. Hoboken, NJ, USA; 2018;47(3):463–70.
Capelli P, Martignoni G, Pedica F, et al. Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med. 2009;133:350–64.
Malago R, D’Onofrio M, Zamboni GA, et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. Am J Roentgenol. 2009;192:424–30.
D’Onofrio M, Mansueto GC, Falconi M, et al. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging. 2004;29:246–58.
Procacci C, Carbognin G, Accordini S, et al. Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol. 2001;11:1175–83.
Eriksson B, Orlefors H, Oberg K, et al. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:311–24.
Koyama K, Okamura T, Kawabe J, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med. 2001;15:217–24.
Papos M, Takacs T, Pavics L, et al. The role of FDG-PET scan in the diagnosis of pancreatic carcinoma. Orv Hetil. 2002;43:1283–6.
Pasquali C, Rubello D, Sperti C, et al. Neuroendocrine tumor imaging, can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg. 1998;22:588–92.
Dietrich CF, Hocke M, Gallotti A, D’Onofrio M. Solid pancreatic tumors. In: D’Onofrio M, editor. Ultrasonography of the pancreas. Berlin, Heidelberg/New York: Springer; 2012. p. 93–110.
Martinez-Noguera A, D’Onofrio M. Ultrasonography of the pancreas. 1. Conventional imaging. Abdom Imaging. 2007;32:136–49.
Hohl C, Schmidt T, Honnef D, et al. Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging. 2007;32:150–60.
D’Onofrio M, Mansueto G, Vasori S, et al. Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med. 2003;22:413–7.
D’Onofrio M, Zamboni G, Faccioli N, et al. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging. 2007;32:171–81.
Jung SE, Seung EJ, Kang HL, et al. CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol. 2007;62:371–7.
Rockall AG, Reznek RH. Imaging of neuroendocrine tumors (CT/MR/US). Best Pract Res Clin Endocrinol Metab. 2007;21(1):43–68.
Horton KM, Hruban RH, Yeo C, et al. Multi-detector row CT of pancreatic islet cell tumors. Radiographics. 2006;26:453–64.
McAuley G, Delaney H, Colville J, et al. Multimodality preoperative imaging pancreatic insulinomas. Clin Radiol. 2005;60:1039–50.
D’Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors, tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250(2):407–16.
Owen NJ, Sohaib SA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumors. Br J Radiol. 2001;74:968–73.
Nishie A, Obuchi M, Howe J, et al. Small islet cell tumour in the pancreas, diagnostic value of diffusion-weighted MRI. J Med Imaging Radiat Oncol. 2008;52(4):374–5.
Furukawa H, Mukai K, Kosuge T, et al. Nonfunctioning islet cell tumors of the pancreas: clinical, imaging and pathological aspects in 16 patients. Jpn J Clin Oncol. 1998;28:255–61.
Hoff A, Cote G, Gagel R. Management of neuroendocrine cancers of the gastrointestinal tract: islet cell carcinoma of the pancreas and other neuroendocrine carcinomas. In: Abbruzzese J, Evans D, Willett C, Fenoglio-Preiser C, editors. Gastrointestinal oncology. New York: Oxford University Press; 2004. p. 780–800.
Demos TC, Posniak HV, Harmath C, et al. Cystic lesions of the pancreas. AJR Am J Roentgenol. 2002;179:1375–88.
Roggli VL, Judge DM, McGavran MH. Duodenal glucagonoma: a case report. Hum Pathol. 1979;10:350–3.
Capelli P, Parisi A. Pancreatic lesions: pathologic correlation. Chapter 12. In: D’Onofrio M, editor. Ultrasonography of the pancreas. Imaging and pathologic correlations. Berlin, Heidelberg/New York: Springer; 2012. p. 165–86.
Graziani R, Brandalise A, Bellotti M, et al. Imaging of neuroendocrine gastroenteropancreatic tumours. Radiol Med. 2010;115:1047–64.
Bordeianou L, Vagefi PA, Sahani D, et al. Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg. 2008;206:1154–8.
Shimizu K, Shiratori K, Toki F, et al. Nonfunctioning islet cell tumor with a unique pattern of tumor growth. Dig Dis Sci. 1999;44:547–51.
Yazawa N, Imaizumi T, Okada K, et al. Nonfunctioning pancreatic endocrine tumor with extension into the main pancreatic duct: report of a case. Surg Today. 2011;41:737–40.
Heller SJ, Ferrari AP, Carr-Locke DL, et al. Pancreatic duct stricture caused by islet cell tumors. Am J Gastroenterol. 1996;91:147–9.
Uemura K, Murakami Y, Hayashidani Y, et al. Main pancreatic duct obstruction due to a small nonfunctioning endocrine tumor of the pancreas. Hiroshima J Med Sci. 2009;58:45–8.
Powell AC, Hajdu CH, Megibow AJ, et al. Nonfunctioning pancreatic endocrine neoplasm presenting as asymptomatic, isolated pancreatic duct stricture: a case report and review of the literature. Am Surg. 2008;74:168–71.
Ogawa M, Kawaguchi Y, Maruno A, et al. Small serotonin-positive pancreatic endocrine tumors caused obstruction of the main pancreatic duct. World J Gastroenterol. 2012;18:6669–73.
Koljenovic S, van Eijck CH, den Bakker MA. Pigmented black neuroendocrine tumour of the pancreas diagnosed by fine needle aspiration cytology. Cytopathology. 2010;21:270–2.
Smith AE, Levi AW, Nadasdy T, et al. The pigmented “black” neuroendocrine tumor of the pancreas: a question of origin. Cancer. 2001;92:1984–91.
Fryer E, Serra S, Chetty R. Lipid-rich (“clear cell”) neuroendocrine tumors of the pancreas in MEN I patients. Endocr Pathol. 2012;23:243–6.
Singh R, Basturk O, Klimstra DS, et al. Lipid-rich variant of pancreatic endocrine neoplasms. Am J Surg Pathol. 2006;30:194–200.
Ligneau B, Lombard-Bohas C, Partensky C, et al. Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. Am J Surg Pathol. 2001;25:752–60.
Sidden CR, Mortele KJ. Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28:339–56.
Deshpande V, Lauwers GY. Cystic pancreatic endocrine tumor: a variant commonly confused with cystic adenocarcinoma. Cancer. 2007;111:47–53.
Tamagno G, Maffei P, Pasquali C, et al. Clinical and diagnostic aspects of cystic insulinoma. Scand J Gastroenterol. 2005;40:1497–501.
Zamboni G, Pea M, Martignoni G, et al. Clear cell “sugar” tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol. 1996;20:722–30.
Buetow PC, Miller DL, Parrino TV. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. Radiographics. 1999;17:453–72.
D’Onofrio M, et al. Pancreas. In: Weskott HP, editor. Contrast-enhanced ultrasound. Bremen: UNI-MED Verlag AG; 2011.
Klein KA, Stephens SH, Welch TJ. Imaging of metastatic disease to the pancreas (abstr). Radiology. 1995;197:501.
Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.
Bertolotto M, D’Onofrio M, Martone E, et al. Ultrasonography of the pancreas. 3. Doppler imaging. Abdom Imaging. 2007;32(2):161–70.
Becker D, Strobel D, Bernatik T, et al. Echo-enhanced color and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc. 2001;53:784–9.
Singhi AD, Chu LC, Tatsas AD, et al. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012;36(11):1666–73.
Cloyd JM, Kopecky KE, Norton JA, et al. Neuroendocrine tumors of the pancreas: degree of cystic component predicts prognosis. Surgery. 2016;160(3):708–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
De Robertis, R. et al. (2022). Neuroendocrine Neoplasms. In: D'Onofrio, M., Capelli, P., Pederzoli, P. (eds) Imaging and Pathology of Pancreatic Neoplasms. Springer, Cham. https://doi.org/10.1007/978-3-031-09831-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-09831-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09830-7
Online ISBN: 978-3-031-09831-4
eBook Packages: MedicineMedicine (R0)